R-U

Trilocur 50ml Oral Suspension for Dogs is a veterinary medicine used to manage hyperadrenocorticism, often called Cushing’s disease, in dogs. With this condition the body produces too much cortisol for months or years, and the effects can build up gradually. Many owners first notice that their dog drinks far more than normal and needs to urinate more often, including asking to go outside at night or having accidents in the house. Increased appetite, weight gain around the abdomen, heavier panting, and reduced stamina are also common. Some dogs develop thinning hair, fragile skin, or recurrent ear and skin problems, while others seem less interested in exercise or play. Because these signs can overlap with other illnesses, your vet will usually confirm hyperadrenocorticism with a combination of history, examination and laboratory tests before starting Trilocur. Some dogs seem restless and pace, while others become quieter and less keen to exercise. Skin and coat changes can develop over time, including thinning hair, recurrent skin infections, slow hair regrowth after clipping, and fragile skin that bruises easily. Because these signs can overlap with other illnesses, diagnosis and treatment decisions should always be made by a vet, and Trilocur should only be used under veterinary direction.

Trilocur contains trilostane, a medicine that reduces cortisol production within the adrenal glands. Trilostane works by blocking an enzyme involved in making steroid hormones, so the adrenal glands produce less cortisol and release less into the bloodstream. The effect is reversible, which is helpful because your vet can adjust the dose if cortisol control is not adequate or if the effect becomes too strong. Trilocur does not remove the underlying cause of Cushing’s disease, but by lowering cortisol it can reduce the impact of the disease and help a dog feel more comfortable day to day. When Trilocur is working well, owners often notice steadier drinking and urination patterns, less panting, and an improved level of energy. Coat and skin improvements can take longer and tend to be more gradual. The goal is stable control over time, rather than rapid change in a few days.

Trilotab 60mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome

60mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.

Administered orally, 60mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.

VETERINARY PRESCRIPTION REQUIRED

Trilotab 30mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome

30mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.

Administered orally, 30mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.

VETERINARY PRESCRIPTION REQUIRED

Rheumocam for Dogs is a prescription-only oral suspension specifically formulated to provide relief from inflammation and pain associated with acute and chronic musculo-skeletal disorders in dogs.

200ml Rheumocam offers a practical solution for pet owners seeking to manage their dog's health conditions effectively.

Rheumocam works by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), which play a crucial role in the synthesis of prostaglandins. Prostaglandins are lipid compounds that contribute to inflammation, pain, and fever. By reducing the production of these compounds, Rheumocam effectively alleviates discomfort and improves mobility in dogs suffering from various musculo-skeletal conditions.

Rheumocam for Dogs is a highly effective oral solution designed to alleviate inflammation and pain associated with acute and chronic musculo-skeletal disorders in dogs. Rheumocam is available in a 100ml bottle, ensuring your pet receives the precise dosage for optimal health and mobility.

Rheumocam workd by inhibiting the enzymes responsible for producing prostaglandins, which are chemicals that contribute to inflammation, pain, and fever. By reducing these prostaglandins, Rheumocam effectively diminishes inflammation and pain, offering relief to dogs suffering from conditions such as arthritis, injuries, or surgeries.

Inflammation and pain can significantly impact your dog's quality of life, leading to decreased activity, discomfort, and potential progression of musculo-skeletal disorders. 100ml Rheumocam for Dogs plays a crucial role in managing these symptoms, promoting a more active and comfortable life for your pet.

64mg Reconcile for Dogs is a veterinary prescription medication that contains fluoxetine.

Reconcile 64mg is available as chewable tablets and it's indicated as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination).

Reconcile for Dogs aids in the treatment of separation-related disorders in dogs. These disorders are often manifested by destructive and inappropriate behaviours, such as vocalisation and inappropriate defecation and/or urination, particularly when the dog is left alone.

Reconcile 64mg for Dogs is a once-a-day, flavoured, chewable tablet that is prescribed by your veterinarian. The active ingredient is fluoxetine, an antidepressant that works by increasing the levels of serotonin in the dog's brain. This helps to achieve a calmer frame of mind in dogs, making them more receptive to behaviour modification training.

Separation anxiety is a condition that affects up to 17% of dogs. It can be inherited or acquired, depending on the dog’s history and experiences. The anxiety develops when the dog is unable to soothe their anxiety without the assistance of their caregiver, or when being alone is associated with uncertainty or fear-inducing signals such as noise. Separation anxiety is a common condition in dogs, causing distress when they are left alone. Affected dogs may exhibit destructive behaviours, excessive barking, inappropriate urination, or attempts to escape. Reconcile is prescribed alongside a structured behavioural modification programme to help dogs develop healthier coping mechanisms and reduce anxiety symptoms over time.

VETERINARY PRESCRIPTION REQUIRED

32mg Reconcile for Dogs

Reconcile 32mg is a veterinary-prescribed tablet used to help manage separation anxiety in dogs. Reconcile is an effective treatment designed to work alongside behavioural training programmes recommended by veterinary professionals. Dogs suffering from separation anxiety often display distress and unwanted behaviours when left alone. Reconcile can help reduce these symptoms, making it easier for dogs to adapt to periods of separation.

What is Reconcile 32mg?

Reconcile contains the active ingredient fluoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI). It is a chewable tablet that has been flavoured to encourage acceptance by dogs. Reconcile is specifically approved for use in dogs to target the symptoms of separation anxiety.

By adjusting the balance of serotonin in the brain, Reconcile helps regulate mood and emotions. Serotonin is a neurotransmitter that plays a vital role in feelings of well-being. In dogs with separation anxiety, serotonin levels can be disrupted, leading to anxiety-driven behaviours. Reconcile works by helping restore this balance, supporting calmer responses in stressful situations.

How Reconcile Works

Fluoxetine, the main component of Reconcile, increases the availability of serotonin in the brain by preventing its reabsorption into nerve cells. This mechanism allows serotonin to remain active for longer periods, positively influencing mood regulation.

Dogs prescribed Reconcile typically begin treatment while also undergoing behavioural modification plans. The medication does not replace training but supports it. Reconcile allows dogs to respond more effectively to training by reducing the overwhelming anxiety that interferes with learning. Over time, this combination helps reduce behavioural issues and strengthens a dog’s ability to cope with being left alone.

VETERINARY PRESCRIPTION REQUIRED

16mg Reconcile is a prescription medication used to manage separation-related disorders in dogs. Each tablet contains 16mg of fluoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI) that helps regulate mood and reduce anxiety.

Reconcile is prescribed for dogs experiencing distress when left alone. It is designed to be used alongside behavioural modification therapy to help dogs develop healthier coping mechanisms. This medication can improve a dog's overall well-being by reducing anxiety-driven behaviours.

How 16mg Reconcile Works

Reconcile 16mg contains fluoxetine hydrochloride, an SSRI that increases serotonin levels in the brain. Serotonin is a neurotransmitter responsible for regulating mood, emotions, and behaviour. Low serotonin levels can contribute to anxiety, stress, and compulsive behaviours.

Fluoxetine works by preventing the reabsorption of serotonin in the brain, allowing more of the chemical to remain active. This helps stabilise mood and reduce the emotional distress that leads to unwanted behaviours in dogs with separation-related disorders.

Reconcile does not cause immediate changes in behaviour. It takes several weeks for the medication to reach full effectiveness, during which time dogs may gradually show signs of reduced anxiety and improved responses to training.

VETERINARY PRESCRIPTION REQUIRED

Simparica Trio 72mg Chewable Tablets for Dogs (40kg-60kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 6

Simparica Trio 72mg Chewable Tablets for Dogs (40kg-60kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3

Simparica Trio 48mg Chewable Tablets for Dogs (20kg-40kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 6

Simparica Trio 48mg Chewable Tablets for Dogs (20kg-40kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3